Skip to main content

Enrollment in the Health Benefits for Immigrant Adults (HBIA) program will be temporarily paused effective July 1, 2023.

Enrollment in the Health Benefits for Immigrant Seniors (HBIS) program will be temporarily paused effective Nov. 6, 2023.

Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Meeting Results June 17, 2009

Drug Name Review Type Committee Recommendation Prior Approval Status � Final Determination
Texacort New Drug Initial Review Require Prior Approval Prior Approval Required
CNL8 Nail Kit New Drug Initial Review Require Prior Approval Prior Approval Required
Flector Patch New Drug Initial Review Require Prior Approval Prior Approval Required
Kapidex New Drug Initial Review Require Prior Approval Prior Approval Required
Cinryze New Drug Initial Review Require Prior Approval Prior Approval Required
Banzel New Drug Initial Review Require Prior Approval Prior Approval Required
Vimpat New Drug Initial Review Require Prior Approval Prior Approval Required
Durezol New Drug Initial Review Require Prior Approval Prior Approval Required
Aplenzin New Drug Initial Review Require Prior Approval Prior Approval Required
Simponi New Drug Initial Review Require Prior Approval Prior Approval Required
Zanaflex Capsules New Drug Initial Review Require Prior Approval Prior Approval Required
Rapaflo New Drug Initial Review Require Prior Approval Prior Approval Required
Gelnique New Drug Initial Review Require Prior Approval Prior Approval Required
Equetro New Drug Appeal Removed From Agenda Prior Approval Required
Zemplar New Drug Appeal Require Prior Approval Prior Approval Required
Trilipix New Drug Appeal Remove Prior Approval Requirement Prior Approval Requirement Removed
Simcor New Drug Appeal Require Prior Approval Prior Approval Required
Vigamox PDL Appeal Remove Prior Approval Requirement Prior Approval Required